New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 30, 2013
10:00 EDTXNCR, BANX, ETR, WLB, EOX, OCRXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiation include: Entergy (ETR) coverage resumed with a Neutral at Goldman... Ocera Therapeutics (OCRX) initiated with a Buy at Stifel... StoneCastle (BANX) initiated with a Market Perform at JMP Securities... Westmoreland Coal (WLB) initiated with a Buy at Brean Capital... Emerald Oil (EOX) initiated with an Outperform at Iberia... Xencor (XNCR) initiated with an Outperform at Leerink.
News For ETR;OCRX;WLB;BANX;EOX;XNCR From The Last 14 Days
Check below for free stories on ETR;OCRX;WLB;BANX;EOX;XNCR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2014
07:03 EDTETREntergy raises FY14 EPS to $5.55-$6.75 from $4.60-$5.40, consensus $5.33
Subscribe for More Information
07:02 EDTETREntergy sees Q1 operational EPS $2.28, consensus $1.15
Subscribe for More Information
April 10, 2014
08:03 EDTXNCRXencor Merck receives milestone payment from Merck for using XmAb antibody
Xencor (XNCR) announced that the company has received a milestone payment from Merck (MRK), through a subsidiary, triggered by the initiation of a Phase 1 clinical trial for an undisclosed biologic drug candidate that uses Xencor's XmAb antibody engineering intellectual property. Under the terms of the agreement signed in June 2013, Xencor granted Merck a non-exclusive license to certain Xencor patents for use in an undisclosed product, as well as an option to license the same intellectual property for future products. Xencor received an upfront payment and continues to receive annual maintenance fees. Xencor is also eligible to receive milestone payments associated with the successful development of Merck product candidates, as well as royalties on sales of any potential products that may result from this agreement.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use